Skip to Main Content

Paper Details

Correlative studies of the Breast Cancer Index (HOXB13/IL17BR) and ER, PR, AR, AR/ER ratio and Ki67 for prediction of extended endocrine therapy benefit: a Trans-aTTom study.
Breast Cancer Res
2
2022
AR, BCI, BCI (H/I) gene, Breast Cancer, EET, ER, HER2, HOXB13, HR, IL17BR, Ki67, PR, androgen, androgen receptors, breast cancer, estrogen, patients, progesterone, tamoxifen, tumor
Author NameAffiliation
Dennis C SgroiMolecular Pathology Research Unit, Harvard Medical School, Massachusetts General Hospital East
Dennis C SgroiMassachusetts General Hospital Center for Cancer Research, Harvard Medical School
Tammy PiperUniversity of Edinburgh
Karen J TaylorUniversity of Edinburgh
Daniel ReaCancer Research UK Clinical Trials Unit, University of Birmingham
John M S BartlettUniversity of Edinburgh
John M S BartlettOntario Institute for Cancer Research
John M S BartlettUniversity of Toronto
  • 1 - 8

Datasets

Release 1.2